- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
Consumer Reports finds growth in sleep aid use
A new article in Consumer Reports Best Buy Drugs is reporting that pharmacists filled 43 million prescriptions for sleep drugs in 2005, a number that is up 32% from 2001. The report also notes that direct-to-consumer advertising contributes to increased use of sleep aids.
Consumer Reports finds growth in sleep aid use
A new article in Consumer Reports Best Buy Drugs is reporting that pharmacists filled 43 million prescriptions for sleep drugs in 2005, a number that is up 32% from 2001. The report also notes that direct-to-consumer advertising contributes to increased use of sleep aids. Newer insomnia drugs, such as Ambien and Ambien CR (zolpidem, Sanofi-Aventis), Lunesta (eszopiclone, Sepracor), Sonata (zaleplon, Jones Pharma), and Rozerem (ramelteon, Takeda), are not necessarily better than the older, less expensive drugs such as OTCs or benzodiazepines, according to Consumers Union, publisher of the report. The newer drugs' side effects can range from dizziness and day-after-sleepiness to cognitive impairment and rebound insomnia. The report urges consumers to speak with their healthcare providers to determine their true need for treatment since behavioral therapy alone can improve sleep habits and attitudes toward sleeping and bedtime.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
Examining Barriers to Care in Diabetic Retinopathy Screening
November 30th 2023Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.
A Three Pronged Approach to Driving Purchasing Compliance Across Your Pharmacy
November 29th 2023Navigate drug shortages successfully! This white paper unveils a 3-step strategy, empowering your pharmacy against the impact of 301 active shortages. Learn from industry leaders, optimize vendor relationships and ensure uninterrupted patient care. Download now for resilience in pharmacy purchasing challenges.
